New research, same mission: improve human health

EPIVAX CEO Anne S. De Groot said
EPIVAX CEO Anne S. De Groot said "tregitope is likely to be an important new tool for clinicians who wish to improve the lives of patients." / PBN FILE PHOTO/MICHAEL PERSSON
If “immunoinformatics” ever becomes a household word, the team at Providence’s EpiVax Inc., led by CEO Dr. Anne S. De Groot, will likely be a central reason why. Immunoinformatics refers to the combination of conventional immunological work done in the lab, with “informatics,” the processing of huge troves of DNA and other protein-based data, to…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display